API
| API | CAS# | Quality Standard | Status |
|---|---|---|---|
| Hydrochlorothiazide | 58-93-5 | USP；EP；CP | CEP, GMP, DMF |
| Indapamide | 26807-65-8 | USP；EP；CP | CEP, GMP, DMF |
| Dacarbazine | 4342-03-4 | USP；EP；CP | CEP, GMP, DMF |
| Pemetrexed Disodium Hemipentahydrate | 357166-30-4 | USP；EP；In-house | CEP, GMP, DMF (US#25640), SWISS DMF(#56268) |
| Pemetrexed Disodium Heptahydrate | 357166-29-1 | EP；In-house | CEP, GMP, DMF |
| Capecitabine | 154361-50-9 | USP；EP；In-house | CEP, GMP, DMF |
| Temozolomide | 85622-93-1 | USP；EP；In-house | CEP, GMP, DMF |
| Nilotinib HCl | 923288-90-8 | USP；EP；In-house | CEP, GMP,DMF (US#031693) |
| Idebenone | 58186-27-9 | CP;In-house | GMP, DMF (US#032079) |
| Ticagrelor | 274693-27-5 | In-house；EP | GMP, DMF, CEP applying |
| Molnupiravir | 2492423-29-5 | In-house | DMF(US# 037087) |
| Clopidogrel Bisulfate | 120202-66-6 | USP；EP；CP | GMP, DMF |
| Bortezomib | 179324-69-7 | In-house | GMP, DMF |
| Oxaliplatin | 61825-94-3 | USP；EP；CP | GMP, DMF |
| Ritodrine HCl | 23239-51-2 | USP；EP；In-house | GMP |
| Fasudil Hydrochloride | 105628-07-7 | CP | GMP |
| Potassium Aspartate | 36221-97-3 | In-house | GMP |
| Erlotinib HCl | 183319-69-9 | In-house；EP | GMP, DMF |
| Esomeprazole Sodium | 161796-78-7 | In-house | GMP |
| Esomeprazole Magnesium | 217087-09-7 | USP；In-house | GMP |
| Tenofovir Disoproxil Fumarate | 202138-50-9 | CP | GMP |
| Tenofovir Alafenamide Fumarate | 1392275-56-7 | In-house | GMP |
| Gefitinib | 184475-35-2 | EP；In-house | GMP, DMF |
| Semaglutide | 910463-68-2 | In-house | Commercial |
| Pregabalin | 148553-50-8 | In-house | Commercial |
| Methocarbamol | 532-03-6 | In-house | Commercial |
| Choline Fenofibrate |
856676-23-8 |
In-house | Commercial |
| Sitagliptin Phosphate Monohydrate | 654671-77-9 | In-house | Commercial |
About lixin
Innovation
Product
Sustainable development
News
Join us
Contact us
